The Plasminogen Content of Commercial Preparations and of Normal Donor Plasma in Relation to the Plasmin Content ot the 1st International Plasmin Reference Preparation

Summary

Kabi human plasminogen and plasmin and two Behringwerke preparations of human plasminogen were examined for antigen content, purity and specific activity with the 1st International W.H.O. human plasmin reference preparation and with the plasminogen content of an 8 donor normal plasma pool. In relation to the plasminogen content of the preparation with the highest specific activity, the 8 donor plasma pool contained 0.186 mg/ ml of plasminogen. This plasminogen on complete conversion to plasmin by streptokinase or urokinase corresponded to 4.35 International units/ml of plasmin as defined by the International reference preparation.

Protein adsorption from highly purified plasminogens of low protein content induced variable underestimates of antigen and of biological activity. To prevent this it is recommended to issue these purified preparations in an inert carrier medium or alternatively to release these preparations with data pertaining to salt content and optical measurement prior to lyophilisation. When standards of high purity and low protein content are being examined for antigen and enzyme, it is recommended likewise that an inert protein carrier should be present in the diluent. Measurement of proactivator was considered to be unsuitable in reference to proactivator content of highly purified plasmin and plasminogen.

• References

• 1 Berg W, Korsan-Bengtsen K, Ygge J. 1966 Determination of plasminogen in human plasma by the lysis time method. Thrombosis Diathesis Haemorrhagica. 16
• 2 Bohlen P, Stein S, Dairman W, Udenfreind S. 1973; Fluorometric assay of proteins in the nanogram range. Archives of Biochemistry and Biophysics 155: 213
• 3 Feinberg JG. 1959; A specific assay method for biological solutions with particular reference to allergen extracts. Immunology 2: 346
• 4 Fletcher AP, Alkjaersig N. 1973. In Poller L. (Ed.) Recent Advances in Thrombosis. Churchill Livingstone; 94
• 5 Gaffney PJ, Brasher M, Lord K, Kirkwood TB L. 1977; Activation of plasminogen as a feature in its assay. Haemostasis 6: 72
• 6 Hedner V, Nilsson IM. 1971; Comparison between a direct and an indirect method for determining plasminogen. Thrombosis et Diathesis Haemorrhagica 26: 291
• 7 Johnson AJ, Kline DL, Alkjaersig N. 1969; Assay methods and standardspreparations for plasmin, plasminogen and urokinase in purified systems 1967-1968. Thrombosis et Diathesis Haemorrhagica 21: 259
• 8 Johnson AJ, Tse A, Skoza L. 1966; Variation in assays of standard SK and plasmin preparations, evidence for and effect of variability of plasmins, plasminogens and fibrinogen. Federation Proceedings 25: 34
• 9 Kirkwood TB L, Cambell PJ, Gaffney PJ. 1975; A standard for human plasmin. Thrombosis et Diathesis Haemorrhagica 34: 20
• 10 Mannucci PM, Stabilini R, Bragotti RM, Ansini B, Agostoni A. 1971; Enzymatic and immunochemical determination of plasminogen and plasmin in different physiological and pathological states. Journal of Clinical Pathology 24: 228
• 11 Margaulit R, Gidron E, Shalitin Y. 1977; A new method for the determination of plasma activators of fibrinolysis. Thrombosis and Haemost 37: 210
• 12 Nanninga LB, Guest MH. 1970; Fibrinolytic activation of plasma by means of urokinase in vitro and in vivo. Thrombosis et Diathesis Haemorrhagica 24: 33
• 13 Remmert LF, Cohen P. 1949; Partial purification and properties of a proteolytic enzyme of human serum. Journal of Biological Chemistry 181: 431
• 14 Regoeczi E. 1968; Occlusion of plasma proteins by human fibrin, studies using trace labelled proteins. British Journal of Haematology 14: 279
• 15 Sgouris JT, Inman JK, Mccall KB, Heydman LA, Anderson HD. 1960; The preparation of human fibrinolysin (plasmin). Vox. Sanguinis 5: 357
• 16 Takada A, Takada Y, Abnis L. 1971; Proactivators in the fibrinolysis system. Thrombosis et Diathesis Haemorrhagica Suppl 47: 31
• 17 De Vreker RA. 1965; A technique for routine evaluation of plasminogen in humans during streptokinase therapy. Acta Haematologica 31: 305
• 18 Wadell WJ. 1956; A simple ultraviolet spectrophotometric method for the determination of protein. Journal of Laboratory and Clinical Medicine 48: 311
• 19 Wallen P, Wiman B. 1975. On the generation of intermediate plasminogen and its significance for activation. In Proteases and Biological Control. Cold Spring Harbour Laboratory; 291
• 20 Weber K, Osborn M. 1969; The reliability of mol. wt. determinations by dodecyl sulphate polyacrylamide gel electrophoresis« Journal of Biological Chemistry 244: 4406
• 21 Wolf P. 1968; Modification of the fibrin agar plate for measurement of the components of the fibrinolytic system. I) The measurements of plasminogen on type I fibrin agar plates. Thrombosis et Diathesis Haemorrhagica 20: 50
• 22 Wolf P. 1968; Fibrinolytic activity and coronary artery disease. Lancet 1: 1312
• 23 Wolf P. 1973; The reliability of plasminogen estimation by activation potential. Bibliotheca Anatomica 12: 286